BACKGROUND: The goal of the current study was to assess the rates of recurrence in the neck for patients with lymph node-positive human papillomavirus-associated cancer of the oropharynx who were treated with definitive radiotherapy (with or without chemotherapy). METHODS: This is a single-institution retrospective study. Methodology included database search, and statistical testing including frequency analysis, Kaplan-Meier tests, and comparative tests including chi-square, logistic regression, and log-rank. RESULTS: The cohort consisted of 401 patients with lymph node-positive disease who underwent radiotherapy between January 2006 and June 2012. A total of 388 patients had computed tomography restaging, and 251 had positron emission tomography and/or ultrasound as a component of their postradiation staging. Eighty patients (20%) underwent neck dissection, and 21 patients (26%) had a positive specimen. The rate of neck dissection increased with increasing lymph node stage, and was lower in patients who had positron emission tomography scans or ultrasound in addition to computed tomography restaging. The median follow-up was 30 months. The 2-year actuarial neck recurrence rate was 7% and 5%, respectively, in all patients and those with local control. Lymph node recurrence rates were greater in current smokers (P = .008). There was no difference in lymph node recurrence rates noted between patients who did and those who did not undergo a neck dissection (P = .4) CONCLUSIONS: A treatment strategy of (chemo)radiation with neck dissection performed based on response resulted in high rates of regional disease control in patients with human papillomavirus-associated oropharyngeal cancer.
BACKGROUND: The goal of the current study was to assess the rates of recurrence in the neck for patients with lymph node-positive human papillomavirus-associated cancer of the oropharynx who were treated with definitive radiotherapy (with or without chemotherapy). METHODS: This is a single-institution retrospective study. Methodology included database search, and statistical testing including frequency analysis, Kaplan-Meier tests, and comparative tests including chi-square, logistic regression, and log-rank. RESULTS: The cohort consisted of 401 patients with lymph node-positive disease who underwent radiotherapy between January 2006 and June 2012. A total of 388 patients had computed tomography restaging, and 251 had positron emission tomography and/or ultrasound as a component of their postradiation staging. Eighty patients (20%) underwent neck dissection, and 21 patients (26%) had a positive specimen. The rate of neck dissection increased with increasing lymph node stage, and was lower in patients who had positron emission tomography scans or ultrasound in addition to computed tomography restaging. The median follow-up was 30 months. The 2-year actuarial neck recurrence rate was 7% and 5%, respectively, in all patients and those with local control. Lymph node recurrence rates were greater in current smokers (P = .008). There was no difference in lymph node recurrence rates noted between patients who did and those who did not undergo a neck dissection (P = .4) CONCLUSIONS: A treatment strategy of (chemo)radiation with neck dissection performed based on response resulted in high rates of regional disease control in patients with human papillomavirus-associated oropharyngeal cancer.
Authors: Min Yao; Russell B Smith; Michael M Graham; Henry T Hoffman; Huaming Tan; Gerry F Funk; Scott M Graham; Kristi Chang; Kenneth J Dornfeld; Yusuf Menda; John M Buatti Journal: Int J Radiat Oncol Biol Phys Date: 2005-08-15 Impact factor: 7.038
Authors: Douglas K Frank; Kenneth S Hu; Bruce E Culliney; Mark S Persky; Moses Nussbaum; Stimson P Schantz; Stephen C Malamud; Roy A Holliday; Azita S Khorsandi; Roy B Sessions; Louis B Harrison Journal: Laryngoscope Date: 2005-06 Impact factor: 3.325
Authors: Shao Hui Huang; Brian O'Sullivan; Wei Xu; Helen Zhao; Duo-duo Chen; Jolie Ringash; Andrew Hope; Albiruni Razak; Ralph Gilbert; Jonathan Irish; John Kim; Laura A Dawson; Andrew Bayley; B C John Cho; David Goldstein; Patrick Gullane; Eugene Yu; Bayardo Perez-Ordonez; Ilan Weinreb; John Waldron Journal: Int J Radiat Oncol Biol Phys Date: 2013-10-24 Impact factor: 7.038
Authors: D M Brizel; K A Leopold; S R Fisher; T J Panella; R L Fine; C L Bedrosian; P D Kenan; A Huang; T Womack; T Bjurstrom Journal: Int J Radiat Oncol Biol Phys Date: 1994-01-01 Impact factor: 7.038
Authors: Stanley L Liauw; Anthony A Mancuso; Robert J Amdur; Christopher G Morris; Douglas B Villaret; John W Werning; William M Mendenhall Journal: J Clin Oncol Date: 2006-03-20 Impact factor: 44.544
Authors: Benjamin J Moeller; Vishal Rana; Blake A Cannon; Michelle D Williams; Erich M Sturgis; Lawrence E Ginsberg; Homer A Macapinlac; J Jack Lee; K Kian Ang; K S Clifford Chao; Gregory M Chronowski; Steven J Frank; William H Morrison; David I Rosenthal; Randal S Weber; Adam S Garden; Scott M Lippman; David L Schwartz Journal: J Clin Oncol Date: 2009-03-30 Impact factor: 44.544
Authors: David J Adelstein; Yi Li; George L Adams; Henry Wagner; Julie A Kish; John F Ensley; David E Schuller; Arlene A Forastiere Journal: J Clin Oncol Date: 2003-01-01 Impact factor: 44.544
Authors: G Brandon Gunn; Pierre Blanchard; Adam S Garden; X Ronald Zhu; C David Fuller; Abdallah S Mohamed; William H Morrison; Jack Phan; Beth M Beadle; Heath D Skinner; Erich M Sturgis; Merrill S Kies; Kate A Hutcheson; David I Rosenthal; Radhe Mohan; Michael T Gillin; Steven J Frank Journal: Int J Radiat Oncol Biol Phys Date: 2016-02-12 Impact factor: 7.038
Authors: G Brandon Gunn; Chase C Hansen; Adam S Garden; Clifton D Fuller; Abdallah S R Mohamed; William H Morrison; Steven J Frank; Beth M Beadle; Jack Phan; Gregory M Chronowski; Erich M Sturgis; Carol M Lewis; Charles Lu; Kate A Hutcheson; Tito R Mendoza; Charles S Cleeland; David I Rosenthal Journal: Radiother Oncol Date: 2015-09-21 Impact factor: 6.280
Authors: R Maquieira; S K Haerle; G F Huber; A Soltermann; S R Haile; S J Stoeckli; Martina A Broglie Journal: Eur Arch Otorhinolaryngol Date: 2015-06-10 Impact factor: 2.503
Authors: Sara Shoultz-Henley; Adam S Garden; Abdallah S R Mohamed; Tommy Sheu; Michael H Kroll; David I Rosenthal; G Brandon Gunn; Amos J Hayes; Chloe French; Hillary Eichelberger; Jayashree Kalpathy-Cramer; Blaine D Smith; Jack Phan; Zeina Ayoub; Stephen Y Lai; Brian Pham; Merrill Kies; Kathryn A Gold; Erich Sturgis; Clifton D Fuller Journal: Int J Cancer Date: 2015-10-09 Impact factor: 7.396
Authors: Salman A Eraj; Mona K Jomaa; Crosby D Rock; Abdallah S R Mohamed; Blaine D Smith; Joshua B Smith; Theodora Browne; Luke C Cooksey; Bowman Williams; Brandi Temple; Kathryn E Preston; Jeremy M Aymard; Neil D Gross; Randal S Weber; Amy C Hessel; Renata Ferrarotto; Jack Phan; Erich M Sturgis; Ehab Y Hanna; Steven J Frank; William H Morrison; Ryan P Goepfert; Stephen Y Lai; David I Rosenthal; Tito R Mendoza; Charles S Cleeland; Kate A Hutcheson; Clifton D Fuller; Adam S Garden; G Brandon Gunn Journal: Radiat Oncol Date: 2017-09-09 Impact factor: 3.481
Authors: Hesham Elhalawani; Abdallah S R Mohamed; Baher Elgohari; Timothy A Lin; Andrew G Sikora; Stephen Y Lai; Abdelrahman Abusaif; Jack Phan; William H Morrison; G Brandon Gunn; David I Rosenthal; Adam S Garden; Clifton D Fuller; Vlad C Sandulache Journal: BMC Cancer Date: 2020-09-23 Impact factor: 4.430